Cargando…

Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures

Diabetes mellitus (DM) is a lifelong progressive disease with high morbidity and mortality worldwide. Whereas cardiovascular complications are well-known for DM, increasing evidence indicates that diabetics are predisposed to cancer. Understanding of molecular pathomechanisms of cancer in DM is of g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cebioglu, Melanie, Schild, Hans H., Golubnitschaja, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405313/ https://www.ncbi.nlm.nih.gov/pubmed/23199047 http://dx.doi.org/10.1007/s13167-010-0015-4

Ejemplares similares

‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention
por: Debald, Manuel, et al.
Publicado: (2013)

Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Inadequate diabetic care: global figures cry for preventive measures and personalized treatment
por: George, Babitha, et al.
Publicado: (2010)

Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments
por: Yeghiazaryan, Kristina, et al.
Publicado: (2011)

Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine
por: Golubnitschaja, Olga
Publicado: (2010)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Innovative strategies for prediction and targeted prevention of glaucoma in healthy vasospastic individuals: context of neurodegenerative pathologies
por: Yeghiazaryan, Kristina, et al.
Publicado: (2014)

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale
por: Golubnitschaja, Olga
Publicado: (2010)

Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Prevalence, predisposition and prevention of type II diabetes
por: Cheng, Dong
Publicado: (2005)

Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs
por: Yeghiazaryan, Kristina, et al.
Publicado: (2010)

The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine
por: Golubnitschaja, Olga
Publicado: (2013)

Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Body Temperature of the Goorkha : Considered in Connection with a Predisposition to Pulmonary Phthisis
por: Lalor, N. P. O'G.
Publicado: (1901)

Time for new guidelines in advanced healthcare: the mission of The EPMA Journal to promote an integrative view in predictive, preventive and personalized medicine
por: Golubnitschaja, Olga
Publicado: (2012)

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2018)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Promoting predictive, preventive and personalised medicine: European event of global importance
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Vision of the first EPMA center for predictive, preventive and personalized medicine in Europe
por: Kapalla, Marko, et al.
Publicado: (2014)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours
por: Golubnitschaja, Olga, et al.
Publicado: (2016)

Predisposition for and Prevention of Subjective Tinnitus Development
por: Ahlf, Sönke, et al.
Publicado: (2012)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
por: Qian, Shehua, et al.
Publicado: (2019)

Gender specific complications in female diabetic patients: an integrative view
por: Golubnitschaja, Olga
Publicado: (2014)

Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine
por: Richter, Kneginja, et al.
Publicado: (2021)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Genetic predisposition to obesity leads to increased risk of type 2 diabetes
por: Li, S., et al.
Publicado: (2011)

Predisposition to Proinsulin Misfolding as a Genetic Risk to Diet-Induced Diabetes
por: Alam, Maroof, et al.
Publicado: (2021)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine
por: Acker, Jens, et al.
Publicado: (2021)

Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?
por: Sjödahl, Krister, et al.
Publicado: (2010)

Diabetes predisposition inherited through maternal germline
por: Zhu, Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t0puahck3cks7965tm98anl75m